The effect of melatonin on prevention of bisphosphonate-related osteonecrosis of the jaw: an animal study in rats
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Melatonin induces human stem cells, converts pre-osteoblasts to mature osteoblasts, and reduces the duration of this transition. However, melatonin itself prevents activation of osteoclasts. Here, we evaluate the role of melatonin in prevention of bisphosphonate-related osteonecrosis of the jaw.Materials and Methods: In this experimental-interventional study, 30 rats were evaluated in 3 groups. The first and second groups received saline and zoledronic acid, respectively, for 4 weeks and the third group received 4 weeks of zoledronic acid and 3 weeks of melatonin simultaneously. First-right-maxillary-molar extraction was performed for all animals, which were sacrificed after 4 weeks of recovery. The extraction sockets were examined histologically for the presence of osteonecrosis, number of osteoclasts and fibroblasts, severity of inflammation, and vascularization. Data were ana-lyzed by chi-square, one-way ANOVA, Tukey, Kruskal–Wallis and Fisher’s exact statistical tests (α=0.05). Results: Osteonecrosis was observed in 20%, 90%, and 70% of the first, second and third groups, respectively (P=0.008). The lowest number of os-teoclasts and fibroblasts was seen in the third group.Conclusion: Melatonin may effectively prevent some undesirable side effects of bisphosphonates. However, further studies are required to confirm the results of this study.
Abstract
Objectives: Melatonin induces human stem cells, converts pre-osteoblasts to mature osteoblasts, and reduces the duration of this transition. However, melatonin itself prevents activation of osteoclasts. Here, we evaluate the role of melatonin in prevention of bisphosphonate-related osteonecrosis of the jaw.Materials and Methods: In this experimental-interventional study, 30 rats were evaluated in 3 groups. The first and second groups received saline and zoledronic acid, respectively, for 4 weeks and the third group received 4 weeks of zoledronic acid and 3 weeks of melatonin simultaneously. First-right-maxillary-molar extraction was performed for all animals, which were sacrificed after 4 weeks of recovery. The extraction sockets were examined histologically for the presence of osteonecrosis, number of osteoclasts and fibroblasts, severity of inflammation, and vascularization. Data were ana-lyzed by chi-square, one-way ANOVA, Tukey, Kruskal–Wallis and Fisher’s exact statistical tests (α=0.05). Results: Osteonecrosis was observed in 20%, 90%, and 70% of the first, second and third groups, respectively (P=0.008). The lowest number of os-teoclasts and fibroblasts was seen in the third group.Conclusion: Melatonin may effectively prevent some undesirable side effects of bisphosphonates. However, further studies are required to confirm the results of this study.
참고문헌 (35)
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update", J Oral Maxillofac Surg, 72, pp.1938~1956 (2014)[DOI]
- Ikebe T, "Pathophysiology of BRONJ : drug-related osteoclastic disease of the jaw", Oral Sci Int, 10, pp.1~8 (2013)[DOI]
- Kaibuchi N, "Multipotent mesenchymal stromal cell sheet therapy for bisphosphonaterelated osteonecrosis of the jaw in a rat model", Acta Biomater, 42, pp.400~410 (2016)[DOI]
- Colella G, "American Association of Oral and Maxillofacial Surgeons position paper: bisphosphonate-related osteonecrosis of the jaws-2009 update: the need to refine the BRONJ definition", J Oral Maxillofac Surg, 67, pp.2698~2699 (2009)[DOI]
- Kos M, "Bisphosphonaterelated osteonecrosis of the jaws: a review of 34 cases and evaluation of risk", J Craniomaxillofac Surg, 38, pp.255~259 (2010)[DOI]
- Otto S, "Bisphosphonate-related osteonecrosis of the jaws-characteristics, risk factors, clinical features, localization and impact on oncological treatment", J Craniomaxillofac Surg, 40, pp.303~309 (2012)[DOI]
- Pichardo SE, "Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?", Oral Surg Oral Med Oral Pathol Oral Radiol, 116, pp.287~292 (2013)[DOI]
- Vaszilko M, "Potential significance of antiestrogen therapy in the development of bisphosphonate related osteonecrosis of the jaw", J Craniomaxillofac Surg, 42, pp.1932~1936 (2014)[DOI]
- Voss PJ, "Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients", J Craniomaxillofac Surg, 40, pp.719~725 (2012)[DOI]
- "Osteonecrosis"[URL]
- "Osteonecrosis of the jaw"[URL]
- Keskinruzgar A, "Histopathological effects of teriparatide in medication-related osteonecrosis of the jaw : an animal study", J Oral Maxillofac Surg, 74, pp.68~78 (2016)[DOI]
- Dayisoylu EH, "The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study", Int J Oral Maxillofac Surg, 42, pp.1475~1480 (2013)[DOI]
- Zandi M, "Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw : a randomized, controlled preclinical study in rats", J Craniomaxillofac Surg, 45, pp.275~280 (2017)[DOI]
- Del Fabbro M, "Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature", Eur J Cancer, 51, pp.62~74 (2015)[DOI]
- Ogata K, "Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model", Bone, 74, pp.95~105 (2015)[DOI]
- López-Jornet P, "Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: a study of the changes in the jaws", J Oral Maxillofac Surg, 69, pp.2488~2493 (2011)[DOI]
- Yanık S, "Histopathological features of bisphosphonates related osteonecrosis of the jaw in rats with and without vitamin d supplementation", Arch Oral Biol, 65, pp.59~65 (2016)[DOI]
- Koneski F, "In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws", J Craniomaxillofac Surg, 46, pp.230~236 (2018)[DOI]
- Najeeb S, "Therapeutic potential of melatonin in oral medicine and periodontology", Kaohsiung J Med Sci, 32, pp.391~396 (2016)[DOI]
- Carpentieri AR, "Melatonin and periodontal tissues : molecular and clinical perspectives", Pharmacol Res, 125(Pt B), pp.224~231 (2017)[DOI]
- Gómez-Florit M, "Anti-fibrotic and antiinflammatory properties of melatonin on human gingival fibroblasts in vitro", Biochem Pharmacol, 86, pp.1784~1790 (2013)[DOI]
- Ramírez-Fernández MP, "Melatonin promotes angiogenesis during repair of bone defects : a radiological and histomorphometric study in rabbit tibiae", Clin Oral Investig, 17, pp.147~158 (2013)[DOI]
- Soybir G, "The effects of melatonin on angiogenesis and wound healing", Surg Today, 33, pp.896~901 (2003)[DOI]
- Nakamura E, "Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A(MTNR1A)in oral squamous-cell carcinoma", Cancer Sci, 99, pp.1390~1400 (2008)[DOI]
- Cutando A, "Local application of melatonin into alveolar sockets of beagle dogs reduces tooth removal-induced oxidative stress", J Periodontol, 78, pp.576~583 (2007)[DOI]
- Barba-Recreo P, "Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats", J Craniomaxillofac Surg, 42, pp.744~750 (2014)[DOI]
- Zandi M, "Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model", J Craniomaxillofac Surg, 44, pp.271~278 (2016)[DOI]
- Wayama MT, "Diminished progression of periapical lesions with zoledronic acid in ovariectomized rats", J Endod, 41, pp.2002~2007 (2015)[DOI]
- Jabbour Z, "Bacterial profile and bone healing in rats receiving cancer therapeutic doses of bisphosphonates and corticosteroids : a pilot study", Int J Oral Maxillofac Surg, 45, pp.1162~1169 (2016)[DOI]
- Cutando A, "A new perspective in oral health : potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR", ROR in the oral cavity, 2011, pp.56, 944~950
- Kara A, "Immune modulatory and antioxidant effects of melatonin in experimental periodontitis in rats", Free Radic Biol Med, 55, pp.21~26 (2013)[DOI]
- Reiter RJ, "Melatonin in the oral cavity : physiological and pathological implications", J Periodontal Res, 50, pp.9~17 (2015)[DOI]
- Arabacı T, "Therapeutic effects of melatonin on alveolar bone resorption after experimental periodontitis in rats: a biochemical and immunohistochemical study", J Periodontol, 86, pp.874~881 (2015)[DOI]
- Ruggierro SL, "Oral and maxillofacial surgery", pp.507~522 (2018), Elsevier
